Jarro-Dophilus EPS 25 Billion CFU
On sale on the US market (according to the DSLD)
Jarrow Formulas, food supplement from the US market
Jarro-Dophilus EPS 25 Billion CFU (Jarrow Formulas), a food supplement au code-barres 790011030409, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Jarrow Formulas
- Barcode
- 790011030409
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Potato Starch, Hydroxypropyl Methylcellulose, Water, Hypromellose, Ethylcellulose, Sodium Alginate, Medium Chain Triglyceride, Oleic Acid, Stearic Acid, Magnesium Stearate, Ascorbic Acid
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Probiotic Blend | Blend | 413 mg |
| Lacticaseibacillus rhamnosus R0011 | Micro-organism | not stated |
| Lactobacillus helveticus R0052 | Micro-organism | not stated |
| Pediococcus acidilactici R1001 | Micro-organism | not stated |
| Lacticaseibacillus casei R0215 | Micro-organism | not stated |
| Bifidobacterium longum BB536 | Micro-organism | not stated |
| Lactiplantibacillus plantarum R1012 | Micro-organism | not stated |
| Bifidobacterium breve R0070 | Micro-organism | not stated |
| Lactococcus lactis lactis R1058 | Micro-organism | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Jarro-Dophilus EPS
Entered into DSLD on 24 August 2023. Withdrawn from the US market on 4 January 2024 (according to the DSLD).- Active ingredient added : Lactobacillus casei R0215 (quantity not stated)
- Active ingredient added : Lactobacillus plantarum R1012 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus R0011 (quantity not stated)
- Active ingredient added : Lactococcus lactis subsp. lactis R1058 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus casei R0215 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus rhamnosus R0011 (quantity not stated)
- Active ingredient removed : Lactiplantibacillus plantarum R1012 (quantity not stated)
- Active ingredient removed : Lactococcus lactis lactis R1058 (quantity not stated)
Official label: Jarro-Dophilus EPS
Entered into DSLD on 16 June 2022. Withdrawn from the US market on 3 November 2022 (according to the DSLD).- Active ingredient added : Lactobacillus casei R0215 (quantity not stated)
- Active ingredient added : Lactobacillus plantarum R1012 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus R0011 (quantity not stated)
- Active ingredient added : Lactococcus lactis subsp. lactis R1058 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus casei R0215 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus rhamnosus R0011 (quantity not stated)
- Active ingredient removed : Lactiplantibacillus plantarum R1012 (quantity not stated)
- Active ingredient removed : Lactococcus lactis lactis R1058 (quantity not stated)
Official label: Jarro-Dophilus EPS
Entered into DSLD on 22 December 2019. Withdrawn from the US market on 15 October 2021 (according to the DSLD).- Active ingredient added : Lactobacillus casei R0215 (quantity not stated)
- Active ingredient added : Lactobacillus plantarum R1012 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus R0011 (quantity not stated)
- Active ingredient added : Lactococcus lactis subsp. lactis R1058 (quantity not stated)
- Active ingredient added : Probiotic Bacteria Blend (quantity not stated)
- Active ingredient removed : Lacticaseibacillus casei R0215 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus rhamnosus R0011 (quantity not stated)
- Active ingredient removed : Lactiplantibacillus plantarum R1012 (quantity not stated)
- Active ingredient removed : Lactococcus lactis lactis R1058 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (413 mg)
Official label: Jarro-Dophilus EPS
Entered into DSLD on 21 November 2019. Withdrawn from the US market on 2 May 2019 (according to the DSLD).- Active ingredient added : Lactobacillus casei R0215 (quantity not stated)
- Active ingredient added : Lactobacillus plantarum R1012 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus R0011 (quantity not stated)
- Active ingredient added : Lactococcus lactis subsp. lactis R1058 (quantity not stated)
- Active ingredient added : Probiotic Bacteria Blend (quantity not stated)
- Active ingredient removed : Lacticaseibacillus casei R0215 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus rhamnosus R0011 (quantity not stated)
- Active ingredient removed : Lactiplantibacillus plantarum R1012 (quantity not stated)
- Active ingredient removed : Lactococcus lactis lactis R1058 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (413 mg)
Official label: Jarro-Dophilus EPS
Entered into DSLD on 10 October 2014. Withdrawn from the US market on 13 February 2019 (according to the DSLD).- Active ingredient added : Bifidobacterium breve M-16V (quantity not stated)
- Active ingredient added : Lactobacillus casei (quantity not stated)
- Active ingredient added : Lactobacillus plantarum R1012 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus R0011 (quantity not stated)
- Active ingredient added : Lactococcus lactis ssp. lactis (quantity not stated)
- Active ingredient added : Pediococcus acidilactici (quantity not stated)
- Active ingredient added : Probiotic Bacteria Blend (25,000,000,000 Viable Cell(s))
- Active ingredient removed : Bifidobacterium breve R0070 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus casei R0215 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus rhamnosus R0011 (quantity not stated)
- Active ingredient removed : Lactiplantibacillus plantarum R1012 (quantity not stated)
- Active ingredient removed : Lactococcus lactis lactis R1058 (quantity not stated)
- Active ingredient removed : Pediococcus acidilactici R1001 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (413 mg)
Official label: Jarro-Dophilus EPS
Entered into DSLD on 25 April 2014. Withdrawn from the US market on 4 September 2014 (according to the DSLD).- Active ingredient added : Bifidobacterium animalis ssp lactis LAFTI B94 (quantity not stated)
- Active ingredient added : Bifidobacterium breve M-16V (quantity not stated)
- Active ingredient added : Lactobacillus acidophilus LA14 (quantity not stated)
- Active ingredient added : Lactobacillus casei (quantity not stated)
- Active ingredient added : Lactobacillus plantarum R1012 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus R0011 (quantity not stated)
- Active ingredient added : Probiotic Bacteria Blend (25,000,000,000 Viable Cell(s))
- Active ingredient removed : Bifidobacterium breve R0070 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus casei R0215 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus rhamnosus R0011 (quantity not stated)
- Active ingredient removed : Lactiplantibacillus plantarum R1012 (quantity not stated)
- Active ingredient removed : Lactococcus lactis lactis R1058 (quantity not stated)
- Active ingredient removed : Pediococcus acidilactici R1001 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (413 mg)
Official label: Jarro-Dophilus EPS
Entered into DSLD on 24 January 2014. Withdrawn from the US market on 4 November 2013 (according to the DSLD).- Active ingredient added : Bifidobacterium animalis ssp lactis LAFTI B94 (quantity not stated)
- Active ingredient added : Bifidobacterium breve M-16V (quantity not stated)
- Active ingredient added : Lactobacillus acidophilus LA14 (quantity not stated)
- Active ingredient added : Lactobacillus casei (quantity not stated)
- Active ingredient added : Lactobacillus plantarum R1012 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus R0011 (quantity not stated)
- Active ingredient added : Probiotic Bacteria Blend (25,000,000,000 Viable Cell(s))
- Active ingredient removed : Bifidobacterium breve R0070 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus casei R0215 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus rhamnosus R0011 (quantity not stated)
- Active ingredient removed : Lactiplantibacillus plantarum R1012 (quantity not stated)
- Active ingredient removed : Lactococcus lactis lactis R1058 (quantity not stated)
- Active ingredient removed : Pediococcus acidilactici R1001 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (413 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Jarrow Formulas
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Jarro-Dophilus EPS 25 Billion CFU (Jarrow Formulas): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/790011030409-jarro-dophilus-eps-25-billion-cfu-jarrow-formulas, updated 22 February 2024.